Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer. (5th December 2019)

• Record Type: Journal Article
• Authors: Li, Junshu; Su, Xiaolan; Dai, Lei; Chen, Na; Fang, Chao; Dong, Zhexu; Fu, Jiamei; Yu, Yan; Wang, Wenshuang; Zhang, Hantao; Wang, Huiling; Ji, Yanhong; Liu, Yi; Cheng, Lin; Shi, Gang; Zhang, Shuang; Yang, Yang; Deng, Hongxin
• Is Part Of: Carcinogenesis. Volume 41:Number 2(2020)
• Page Start: 235
• Page End: 244
• Publication Date: 2019-12-05
• Subjects: Carcinogenesis -- Periodicals; Cancer -- Genetic aspects -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Periodicals; 616.994071
• DOI: 10.1093/carcin/bgz199
• Languages: English
• ISSNs: 0143-3334

Abstract

Abstract: DNA methylation plays a crucial role in the pathogenesis of various diseases, including colorectal cancer (CRC). However, the global and temporal DNA methylation pattern during initiation and progression of colitis-associated cancer (CAC) are still unknown, including the potential therapeutic strategy of targeting methylation for CAC. In the present study, the global DNA methylation pattern was determined at different time points during CAC using DNA methylation sequencing, followed by the Starburst plot integrating alterations and potential functional prediction analysis. After demonstrating the regulatory role of DNA methyltransferases (DNMTs) on the expression of hub-genes in CRC cells, DNMT inhibitors were administered to treat CAC mice. Our results indicated that 811 genes were hypermethylated at different time points during initiation and progression of CAC. Genes that were downregulated and hypermethylated during CAC, including hub-genes BAD and inositol polyphosphate phosphatase-like 1 ( INPPL1 ), were involved in MAPK signaling pathways, kit receptor signaling pathways, apoptosis and EGF/EGFR signaling pathways. Upregulated DNMTs (DNMT1, DNMT3A and DNMT3B) mediated downregulation and hypermethylation of BAD and INPPL1 in CAC and CRC cells. Low doses of DNMT inhibitors (decitabine (DAC) and azacitidine (AZA)) exerted efficient antitumor effects in CAC, accompanied with upregulation of BAD and INPPL1 expression, and apoptosis induction. In summary, the present study demonstrates the temporal DNA methylation pattern during CAC and provides a novel therapeutic strategy for treating this disease. Abstract : The present study demonstrated the global and temporal DNA methylation pattern during CA initiation and progression, and indicated that hypermethylation of genes involved in several crucial pathways occurred.